Načítá se...
Steroid hormone synthetic pathways in prostate cancer
While androgen deprivation therapy (ADT) remains the primary treatment for metastatic prostate cancer (PCa) since the seminal recognition of the disease as androgen-dependent by Huggins and Hodges in 1941, therapy is uniformly marked by progression to castration-resistant prostate cancer (CRPC) over...
Uloženo v:
| Vydáno v: | Transl Androl Urol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219921/ https://ncbi.nlm.nih.gov/pubmed/25379460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2013.09.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|